Capivasertib is an aminopiperidine compound that functions as a pan-AKT kinase inhibitor. It is used as a pharmaceutical raw material in combination with fulvestrant for the manufacturing of therapies targeting hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer with specific PIK3CA/AKT1/PTEN alterations.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1143532-39-1
Atorvastatin Ethyl Ester
pharmaceutical raw material
로사르탄
active pharmaceutical ingredient
Fondaparinux sodium
anticoagulant active pharmaceutical ingredient
Trabectedin
active pharmaceutical ingredient
(S)-tert-butyl 4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-ylcarbamate
pharmaceutical research compound
4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
JDUBGYFRJFOXQC-KRWDZBQOSA-N
C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4